Table 4.
Survival information of included studies
| Reference | cut-off method | cut-off value | Sample size, n | Follow-up time, months | Survival analysis | Multivariate analysis | OS: HR (95% CI) |
CSS; PFS: HR (95% CI) |
|
|---|---|---|---|---|---|---|---|---|---|
| Low ALI | High ALI | ||||||||
| Chen,2023 | X-tile | 24.81 | 156 | 793 | 35 | OS; CSS | Yes | 1.55(1.11–2.16) | 1.46(1.01–2.10) |
| He,2022 | ROC | 40.50 | 116 | 242 | 101 (range, 2–166) | OS | Yes | 1.338(0.735–2.436) | NA |
| Yin,2020 | ROC | 30 | 171 | 449 | 52.8 ± 39.9 | OS; PFS | Yes | 1.59(1.15–2.19) | 1.26(0.51–3.11) |
| Zhang,2022 | ROC | 39.77 | 253 | 362 | NA | OS; PFS | Yes | 1.34(1.02–1.73) | 1.36(1.04–1.79) |
ALI: advanced lung cancer inflammation index; OS: overall survival; PFS: progression free survival; CSS: cancer specific survival; HR: hazard ratio; CI: confidence interval; NA: not available